
Bio-Rad Laboratories BIO
$ 321.11
0.9%
Quarterly report 2025-Q2
added 07-31-2025
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
28.2 M |
Market Cap[1] |
$ 9.06 B |
EBITDA (LTM) |
$ 288 M |
P/E (LTM) |
-8.15 |
P/S (LTM) |
3.55 |
EPS (LTM) |
-38.93 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 31.53 | 2.35 % | $ 1.4 B | Nasdaq Capital Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Apyx Medical Corporation
APYX
|
$ 3.88 | 3.06 % | $ 134 M | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 17.16 | 7.55 % | $ 2.45 B | Nasdaq Global Select Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 9.41 | 1.73 % | $ 676 M | Nasdaq Global Select Market,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 42.31 | 1.76 % | $ 1.31 B | NYSE,SPB | ||
|
Bruker Corporation
BRKR
|
$ 49.05 | -0.18 % | $ 7.31 K | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 90.05 | -3.91 % | $ 133 B | NYSE,SPB | ||
|
Abbott Laboratories
ABT
|
$ 123.33 | -0.84 % | $ 215 B | NYSE,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.07 | -0.49 % | $ 152 M | Nasdaq Global Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Electromed
ELMD
|
$ 28.18 | -0.19 % | $ 238 M | NYSE American | ||
|
InMode Ltd.
INMD
|
$ 14.03 | -0.07 % | $ 1.11 B | Nasdaq Global Select Market,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 102.67 | 1.12 % | $ 1.3 B | Nasdaq Global Select Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 170.85 | 0.96 % | $ 12.8 B | Nasdaq Global Select Market,SPB | ||
|
Accuray Incorporated
ARAY
|
$ 0.87 | 3.46 % | $ 89.4 M | Nasdaq Global Select Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 18.77 | 1.82 % | $ 433 M | Nasdaq Global Select Market,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 14.72 | -4.48 % | $ 398 M | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.62 | 0.05 % | $ 122 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.36 | 3.03 % | $ 21.9 M | Nasdaq Global Select Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 12.79 | 2.08 % | $ 985 M | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.89 | -5.75 % | $ 73.9 M | Nasdaq Global Select Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Globus Medical
GMED
|
$ 93.47 | 1.09 % | $ 12.7 B | NYSE,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Establishment Labs Holdings
ESTA
|
$ 65.8 | -0.59 % | $ 1.85 B | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.